Progranulin as a biomarker and potential therapeutic agent

Vanessa Abella1, Jesús Pino2, Morena Scotece1

  • 1SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Santiago University Clinical Hospital, Santiago de Compostela, Spain.

Drug Discovery Today
|June 27, 2017
PubMed
Summary

Progranulin, a versatile protein, plays roles in inflammation, cancer, and neuroprotection. Recent research highlights its potential as a therapeutic target and biomarker for various diseases.

Related Concept Videos